Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023

Stock Information for Augmedix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Augmedix Inc.

Commure Completes Merger with Augmedix
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, CNOB, AUGX on Behalf of Shareholders
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Augmedix, Inc. (AUGX)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WISA, EVBN, AUGX on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, FLIC, GATO, AUGX on Behalf of Shareholders
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Merger and Looming Vote on September 27, 2024, of Augmedix, Inc. - AUGX
Augmedix Delivers 27% Revenue Growth for Second Quarter of 2024
Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.